We are live on ! Find out more
BFRA

Biofrontera AG American Depositary Shares
BFRA

Delisted

BFRA was delisted on the 4th of March, 2022.

Back to rankings

6 hedge funds and large institutions have $9.67M invested in Biofrontera AG American Depositary Shares in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 3 → 6 (+3)

45% more capital invested

Capital invested by funds: $6.67M → $9.67M (+$3M)

Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
+$5.3M
2
UBS Group
UBS Group
Switzerland
+$11.6K
3
TRCT
Tower Research Capital (TRC)
New York
+$27

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
OM
1
Opaleye Management
Massachusetts
$4.75M +$5.3M +391,400 New
AIC
2
AWM Investment Company
New York
$3.67M – – –
HA
3
Heartland Advisors
Wisconsin
$1.22M – – –
ANBT
4
American National Bank & Trust
Texas
$12K – – –
UBS Group
5
UBS Group
Switzerland
$10K +$11.6K +856 New
TRCT
6
Tower Research Capital (TRC)
New York
– +$27 +2 New

BFRA Hedge Fund Activity: Q2 2018 in Review

6 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Biofrontera AG American Depositary Shares (BFRA) for Q2 2018, worth a combined $9.67M — up 45% from $6.67M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BFRA positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Opaleye Management, opening a new position worth an estimated $5.3M.

  • 6 institutional investors held Biofrontera AG American Depositary Shares (BFRA) as of Q2 2018, up from 3 in Q1 2018.
  • Funds reported $9.67M of Biofrontera AG American Depositary Shares stock for Q2 2018, up 45% quarter-over-quarter.
  • 3 funds opened new Biofrontera AG American Depositary Shares positions in Q2 2018 and 0 closed out, a net change of +3 holders.
  • The largest Biofrontera AG American Depositary Shares buyer in Q2 2018 was Opaleye Management, an estimated $5.3M added.

Based on aggregated 13F filings for Q2 2018.